U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H30N2O2.C7H8O3S
Molecular Weight 526.687
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-796260 TOSYLATE

SMILES

CC1=CC=C(C=C1)S(O)(=O)=O.CC2(C)C(C(=O)C3=CN(CCN4CCOCC4)C5=C3C=CC=C5)C2(C)C

InChI

InChIKey=PJYFREAJNFLEMS-UHFFFAOYSA-N
InChI=1S/C22H30N2O2.C7H8O3S/c1-21(2)20(22(21,3)4)19(25)17-15-24(18-8-6-5-7-16(17)18)10-9-23-11-13-26-14-12-23;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,15,20H,9-14H2,1-4H3;2-5H,1H3,(H,8,9,10)

HIDE SMILES / InChI
A-796260 is a compound that acts as a potent and selective cannabinoid CB2 receptor agonist. The analgesic effects of A-796260 on activity-induced pain behavior were evaluated in a rat model, the results demonstrated that A-796260 may be a useful new pharmacological compound for further studying CB2 receptor pharmacology and for evaluating its role in the modulation of pain.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P34972
Gene ID: 1269.0
Gene Symbol: CNR2
Target Organism: Homo sapiens (Human)
0.77 nM [Ki]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.
2010-01-14
Patents

Sample Use Guides

Neuropathic pain model in rats: The analgesic effects of A-796260 on activity-induced pain behaviour were evaluated in a rat model of sodium monoiodoacetate (MIA)-induced osteoarthritic (OA) joint pain, observed 20 days following the i.a. injection of MIA. A-796260 demonstrated dose-related (3.5-35 mg/kg) reversal of activity-induced pain behaviour in osteoarthritic (OA) rats with effects comparable to celecoxib (38 mg kg−1 i.p.), a clinically relevant analgesic for OA pain.
Route of Administration: Intraperitoneal
The receptor-binding potencies of A-796260 was determined in [3H]-CP 55,940 competition binding assays performed with membrane preparations generated from recombinant cell lines expressing the human CB1, human CB2, rat CB1 or rat CB2 receptors. A-796260 exhibited high binding potencies at both human and rat CB2 receptors with Ki values of 4.37 and 13.0 nM, respectively
Name Type Language
A-796260 TOSYLATE
Common Name English
METHANONE, (1-(2-(4-MORPHOLINYL)ETHYL)-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)-, 4-METHYLBENZENESULFONATE (1:1)
Preferred Name English
Code System Code Type Description
FDA UNII
RNP93O79DW
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
PUBCHEM
11584524
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY
CAS
895155-27-8
Created by admin on Mon Mar 31 22:10:27 GMT 2025 , Edited by admin on Mon Mar 31 22:10:27 GMT 2025
PRIMARY